Book: the Voice of Reason
A useful side-effect of publishing under a copyleft license is that one can be lazy about formally publishing compilatio…
448 articles
A useful side-effect of publishing under a copyleft license is that one can be lazy about formally publishing compilatio…

Nature, Published online: 29 July 2026; doi:10.1038/d41586-026-02308-8Eliminating polio is within reach — if countries s…

STAT is live-blogging an FDA meeting on Capricor Therapeutics’ treatment for Duchenne muscular dystrophy, which has been…

ProMIS Neurosciences reported positive blinded six-month interim safety and biomarker results from PRECISE-AD, the Phase…

Longevity AI and researchers from Meir Medical Center of the Clalit Health Group announced a joint research collaboratio…

As LLMs compete for doctors' attention, some developers say the science of benchmarking their AI tools for safety and ac…

Ronald Fischer, a most-wanted fugitive, was long hiding in the biotech industry in plain sight, and using an alias more …

An open letter to the board of the American Diabetes Association said the board had badly mishandled an incident at its …

Sen. Rand Paul is forcing Fauci to appear before his Senate panel.…
Every cell contains hundreds of mitochondria, the evolved descendants of what were once symbiotic bacteria. Much of the …

A Trump administration plan to limit visas for graduate student and postdocs to four years is fueling concerns that the …

Plus: Democrats take on Trump over IVF, and Trump's White House releases a new science funding blueprint.…

Researchers at VIB and KU Leuven, together with international collaborators, have discovered that blocking autophagy—the…

I've spent my career studying ageing. Here are the 7 ways I slow my biological clock BBC Science Focus Magazi…

Montana’s first experimental treatment review board has brought three longevity heavyweights into the state’s effort to …

New GSK CEO Luke Miels outlined his strategy to help the company navigate a patent cliff and get on a path toward long-t…

Regulators at the FDA have reiterated concerns that Replimmune does not have adequate data to support an approval of its…

The FDA said a Capricor stem cell treatment for Duchenne muscular dystrophy did not meet a Phase 3 trial's objectives — …

In this edition of STAT Health Tech: A chat with Whoop's new chief medical officer, an update on CMS health tech initiat…

New data on American substance use, concerns of a global HIV resurgence, and more health news from Morning Rounds…
The thymus is primarily noted as being the site of T cell maturation, essential to the supply of new T cells to maintain…
A magnetic resonance imaging (MRI) approach known as diffusion tensor image analysis along the perivascular space (DTI-A…

ProMIS Neurosciences is trying to design a safer amyloid-clearing drug for Alzheimer's. Early results suggest it might b…

One year after launching the CMS Health Tech Ecosystem, officials convened in D.C. to celebrate the Trump administration…